Today, Explained Abortion pills at the Supreme Court
24 snips
May 12, 2026 
Alice Miranda Olsteen, senior health care reporter at Politico who covers abortion-pill access and related policy, breaks down the Supreme Court fight over FDA rules. She explains Louisiana’s legal claims, drugmakers’ defenses, the rise of medication abortions and telehealth, and how state-by-state clashes could reshape access.
AI Snips
Chapters
Transcript
Episode notes
Louisiana's Nationwide Ban Claim And Drugmakers' Pushback
- Louisiana asked the Supreme Court to let a nationwide ban on telehealth mifepristone access take effect immediately, arguing “sovereign injury” because out-of-state prescribing circumvents its laws.
- Drug makers countered that states have no right to erase a federal policy for everyone and that Louisiana showed no sudden emergency justifying an injunction.
Both Sides Invoke States' Rights To Support Opposite Outcomes
- Both sides frame the dispute as a states' rights issue: Louisiana argues other states' liberal policies invade its borders, while defenders say divergence is a natural result of state-level control.
- That clash makes abortion access a continuing federal fight despite Dobbs returning authority to states.
Medication And Telehealth Drive Most Abortions Today
- Medication abortion is now the predominant method: about two thirds of abortions use medication and over a quarter use telehealth for access.
- Restricting telehealth would sharply reduce practical access, especially in medical deserts and provider-shortage regions like parts of California.